DK1831239T3 - Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-lambda-lacton og nøgle-mellemprodukter til denne fremgangsmåde - Google Patents

Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-lambda-lacton og nøgle-mellemprodukter til denne fremgangsmåde

Info

Publication number
DK1831239T3
DK1831239T3 DK05797368.7T DK05797368T DK1831239T3 DK 1831239 T3 DK1831239 T3 DK 1831239T3 DK 05797368 T DK05797368 T DK 05797368T DK 1831239 T3 DK1831239 T3 DK 1831239T3
Authority
DK
Denmark
Prior art keywords
beta
17alpha
bismethylene
pregn
lactone
Prior art date
Application number
DK05797368.7T
Other languages
English (en)
Other versions
DK1831239T5 (da
Inventor
Gyoergy Galik
Judit Horvath
Bela Soeroes
Sandor Maho
Zoltan Tuba
Gabor Balogh
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Application granted granted Critical
Publication of DK1831239T3 publication Critical patent/DK1831239T3/da
Publication of DK1831239T5 publication Critical patent/DK1831239T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
DK05797368.7T 2004-11-30 2005-10-11 Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde DK1831239T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0402466A HUP0402466A2 (en) 2004-11-30 2004-11-30 Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
PCT/HU2005/000111 WO2006059168A1 (en) 2004-11-30 2005-10-11 A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6β,7β;15β,l6β-BISMETHYLENE-17α-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Ϝ-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS

Publications (2)

Publication Number Publication Date
DK1831239T3 true DK1831239T3 (da) 2010-06-28
DK1831239T5 DK1831239T5 (da) 2010-11-22

Family

ID=89985652

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05797368.7T DK1831239T5 (da) 2004-11-30 2005-10-11 Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde

Country Status (16)

Country Link
US (1) US8450476B2 (da)
EP (1) EP1831239B8 (da)
JP (1) JP5129899B2 (da)
CN (1) CN101061132B (da)
AT (1) ATE461934T1 (da)
AU (1) AU2005311060B2 (da)
CA (1) CA2585805C (da)
DE (1) DE602005020185D1 (da)
DK (1) DK1831239T5 (da)
ES (1) ES2342781T3 (da)
HK (1) HK1111168A1 (da)
HU (1) HUP0402466A2 (da)
PL (1) PL1831239T3 (da)
PT (1) PT1831239E (da)
SI (1) SI1831239T1 (da)
WO (1) WO2006059168A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042338A1 (it) * 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
ITMI20061802A1 (it) * 2006-09-22 2008-03-23 Antibioticos Spa Epossidazione di 17-oxo-15,16-metilen steroidi con ilidi di solfossonio
ITMI20072141A1 (it) * 2007-11-08 2009-05-09 Chorisis Srl Procedimento per la preparazione del drospirenone
DE102008026793A1 (de) * 2008-06-02 2009-12-03 Bayer Schering Pharma Aktiengesellschaft C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
CN101768203B (zh) * 2010-03-15 2012-11-28 浙江仙居君业药业有限公司 5β，6β环氧甾体化合物及其制备方法
EP2548881B1 (en) * 2010-03-16 2014-12-17 Taizhou Taifa Pharmaceuticals Co., Ltd Preparation method of drospirenone
ES2419663T3 (es) 2010-08-03 2013-08-21 Newchem S.P.A. Métodos para la preparación de Drospirenona y productos intermedios de la misma
CN112979742B (zh) * 2021-03-01 2022-07-01 泰州职业技术学院 3α，20,20-三羟基-5α-孕甾-18-羧酸-γ-内酯及其制备方法
CN113512086B (zh) * 2021-08-20 2022-11-29 天津信谊津津药业有限公司 一种制备螺内酯中间体坎利酮的方法
CN114874280A (zh) * 2022-06-29 2022-08-09 梯尔希（南京）药物研发有限公司 一种屈螺酮杂质的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH539621A (de) 1966-04-02 1973-07-31 Schering Ag Verfahren zur Herstellung von 15,16B-Methylensteroiden
CH504424A (de) 1968-04-22 1971-03-15 Hoffmann La Roche Verfahren zur Herstellung von neuen Steroiden
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3042136A1 (de) 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
ATE15206T1 (de) 1981-09-21 1985-09-15 Schering Ag 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-1 - one, ihre 3,15-trimethylessigsaeure-ester und ihre herstellung.
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
KR100523409B1 (ko) * 1996-12-11 2005-10-24 지.디. 썰 엘엘씨 9,11-에폭시 스테로이드의 제조방법 및 이 제조방법에유용한 중간체
MXPA04009178A (es) 2002-03-22 2004-11-26 Upjohn Co Proceso para preparar eplerenona.

Also Published As

Publication number Publication date
US20080194812A1 (en) 2008-08-14
WO2006059168A1 (en) 2006-06-08
PT1831239E (pt) 2010-05-06
SI1831239T1 (sl) 2010-06-30
CA2585805A1 (en) 2006-06-08
PL1831239T3 (pl) 2010-08-31
DK1831239T5 (da) 2010-11-22
DE602005020185D1 (de) 2010-05-06
CA2585805C (en) 2009-12-22
JP5129899B2 (ja) 2013-01-30
JP2008521876A (ja) 2008-06-26
US8450476B2 (en) 2013-05-28
AU2005311060A1 (en) 2006-06-08
HU0402466D0 (en) 2005-01-28
EP1831239B8 (en) 2010-09-15
HUP0402466A2 (en) 2006-07-28
EP1831239A1 (en) 2007-09-12
EP1831239B1 (en) 2010-03-24
CN101061132B (zh) 2011-03-30
ATE461934T1 (de) 2010-04-15
AU2005311060B2 (en) 2011-02-03
CN101061132A (zh) 2007-10-24
HK1111168A1 (en) 2008-08-01
ES2342781T3 (es) 2010-07-14

Similar Documents

Publication Publication Date Title
DK1831239T5 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde
CY1119077T1 (el) Παραγωγα πυραζολυλαμινοπυριδινης χρησιμα ως αναστολεις κινασων
NO20064032L (no) DPP-IV inhibitorer
CY1105994T1 (el) Aναδιαταγμενες πεντανολες, μεθοδος για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδων
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
BRPI0413973A (pt) compostos
BRPI0610644B8 (pt) composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável.
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
DK1817326T3 (da) Industriel fremgangsmåde til fremstilling af 17-hydroxy-6-beta, 7-beta, 15-beta, 16-beta-bismethylen-3-oxo-17-alpha-pregn-4-en-21-carboxylsyre-gamma-lacton og nøglemellemprodukter for denne fremgangsmåde
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater
DK1877370T3 (da) Fremgangsmåde til fremstilling af hydrazon-derivater
DK1441724T3 (da) Fremgangsmåde til forögelse af endogene testosteronniveauer
NO20080839L (no) Isotopsubstituerte protonpumpeinhibitorer
GB0327323D0 (en) Novel pharmaceuticals
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
NO20053208D0 (no) Metode for reduktiv dehalogenering.
DK2004149T3 (da) Farmaceutiske sammensætninger indeholdende leflunomid
DE60306636D1 (de) Wachstumhormonsekretionsförderer
ATE440958T1 (de) Biotransformation von colchicinoidverbindungen